Image

A Study of Uveitis in Children <18 Years of Age

A Study of Uveitis in Children <18 Years of Age

Recruiting
17 years and younger
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to collect data regarding clinical features and current/past treatments in children under 18 with uveitis. The main questions it aims to answer are:

  • What are the frequency of uveitis subtypes in children?
  • What are clinical and demographic characteristics overall and within each type of uveitis?

Participants will complete one enrollment visit with their doctor. Participants with uveitis onset \<6 months from enrollment date will also partake in a 12 month chart review.

Eligibility

Inclusion Criteria:

  • Age:
    • Incident cases (onset ≤ 6 months) \<17 years
    • Established cases (onset \> 6 months) \<18 years
  • Diagnosis of any type of uveitis (infectious or noninfectious) in any location except traumatic and post-operative uveitis.
  • Active or inactive uveitis with any treatment status (current / prior / none \[but under surveillance\]).

Exclusion Criteria:

  • Bilateral uveitis with differing etiologies
  • Traumatic uveitis
  • Post-operative uveitis
  • Immediate family member (spouse, biological or legal guardian, child, sibling, parent) who is an investigative site personnel directly affiliated with this study or who is an employee of JAEB Center for Health Research.
  • Ocular disease related to Retinoblastoma, Coat's disease, retinitis pigmentosa, inherited retinal degeneration, Juvenile xanthogranuloma (JXG), or leukemia/malignancy within the eye.

Study details
    Uveitis

NCT07518134

Jaeb Center for Health Research

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.